Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;9(4):237-55.
doi: 10.2174/157016312803305933.

Immunotherapy With Tumor Vaccines for the Treatment of Malignant Gliomas

Affiliations
Review

Immunotherapy With Tumor Vaccines for the Treatment of Malignant Gliomas

Divya Ajay et al. Curr Drug Discov Technol. .

Abstract

With an average life expectancy of 14 months, Glioblastoma multiforme (GBM), is the most aggressive primary brain tumor. Our growing understanding of the immune system and its role in oncogenesis has helped develop cancer vaccines as a promising treatment modality against this disease. What follows is a comprehensive discussion on the history of immunotherapy and the various vaccine based therapies being developed and utilized for the treatment of malignant gliomas.

Similar articles

See all similar articles

Cited by 3 articles

Substances

Feedback